Objective: In this study it is aimed to investigate the efficacy of longacting
risperidone in treatment of schizophrenia.
Method: The files of patients whom diagnosed schizophrenia
according to DSM IV and had been treated with long acting
risperidone in Gaziantep University Medical of Faculty Department of
Psychiatry, Pscyhotic Disorders Unit, was investigated retrospectively.
Results: End of the study clinical improvement was achieved by 66.7%
(20/30). In the course of 6 months follow up period, weight gain in 2
patients (6.6%), late dyskinesia in 1 patient (3.3%), oculogyric crisis
(3.3%), and akathisia in 1 patient (3.3%) was observed.
Conclusion: This is the first study in our country which evaluates the efficacy
of long-acting risperidone treatment for 24 weeks period and long-acting
risperidone was appeared lead to clinical improvement in proportion
%66.7 especially for schizophrenia patients with partial compliance.
Long-acting risperidone, efficacy, schizophrenia